Literature DB >> 32201932

Comment on: "A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance".

J P Hays1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32201932     DOI: 10.1007/s40258-020-00574-9

Source DB:  PubMed          Journal:  Appl Health Econ Health Policy        ISSN: 1175-5652            Impact factor:   2.561


× No keyword cloud information.
  1 in total

1.  Authors' Reply to Hays: "A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance".

Authors:  David J Mott; Grace Hampson; Martin J Llewelyn; Jorge Mestre-Ferrandiz; Michael M Hopkins
Journal:  Appl Health Econ Health Policy       Date:  2020-06       Impact factor: 2.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.